Vivos Therapeutics, Inc.
About Vivos Therapeutics, Inc.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $17.4M
- Net income
- -$21.2M
- Total assets
- $25.2M
- Market cap
- $12.0M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $12.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 11, 2020
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Vivos Therapeutics, Inc..